Narrative review / 2015
An editorial outlines several reasons why anti-obesity pharmacological treatments remain stigmatized.
This editorial discusses why anti-obesity medications are stigmatized despite being useful tools alongside lifestyle modifications. Identified reasons include the failure of short-term medication use to achieve long-term results, the common perception of obesity as a lifestyle choice, and difficulties treating obesity in primary care. Additional factors cited are less than desired weight-loss results, misuse of medications for cosmetic reasons, and an unfavorable history of other anti-obesity drugs withdrawn in previous decades.
- Study type
- Editorial
- Who was studied
- Not applicable
- What was measured
- Reasons for the stigmatization of anti-obesity drugs
THE PAPER
Why are anti-obesity drugs stigmatized?
Halpern B, Halpern A. Expert Opin Drug Saf, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.